IxCell hUC-MSC-S
/ IxCell Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 30, 2025
Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke
(clinicaltrials.gov)
- P2 | N=86 | Not yet recruiting | Sponsor: Shanghai IxCell Biotechnology Co., LTD
New P2 trial • Cardiovascular • Ischemic stroke
December 03, 2024
Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: Shanghai IxCell Biotechnology Co., LTD | Not yet recruiting ➔ Completed
Trial completion • Cardiovascular • Ischemic stroke
January 26, 2023
Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Shanghai IxCell Biotechnology Co., LTD
New P1 trial • Cardiovascular • Ischemic stroke
1 to 3
Of
3
Go to page
1